Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Former Inhibikase CEO launches new biotech for Parkinson’s asset
ABLi Therapeutics licensed a drug discovery platform and Parkinson's candidate risvodetinib from Inhibikase.
Darren Incorvaia
May 12, 2025 12:44pm
Fierce Biotech Fundraising Tracker: Haya, NewLimit & more
May 8, 2025 8:50am
Vivo Capital secures $740M to invest in biotechs
May 7, 2025 4:59pm
NewLimit raises $130M to push liver mRNA med into clinic
May 6, 2025 11:00am
Deerfield unveils $600M healthcare fund
May 5, 2025 10:26am
Biopharma VC dropped 20% in Q1 compared to ’24: GlobalData
Apr 30, 2025 12:33pm
